allogeneic ROR1-targeted CAR-NK cell therapy
/ Oncternal Therap, Karolinska Institute, Celularity
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
November 10, 2022
Pre-Clinical Studies to Advance Zilovertamab-Based, Anti-ROR1 CAR-T cell Therapy for Metastatic Prostate Cancer
(SBUR 2022)
- No abstract available.
1 to 1
Of
1
Go to page
1